BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36833200)

  • 1. Functional Assessment of a New PBX1 Variant in a 46,XY Fetus with Severe Syndromic Difference of Sexual Development through CRISPR-Cas9 Gene Editing.
    Mary L; Leclerc D; Labalme A; Bellaud P; Mazaud-Guittot S; Dréano S; Evrard B; Bigand A; Cauchoix A; Loget P; Lokchine A; Cluzeau L; Gilot D; Belaud-Rotureau MA; Jaillard S
    Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of a novel PBX1 de novo missense variant identified in a patient with syndromic congenital heart disease.
    Alankarage D; Szot JO; Pachter N; Slavotinek A; Selleri L; Shieh JT; Winlaw D; Giannoulatou E; Chapman G; Dunwoodie SL
    Hum Mol Genet; 2020 May; 29(7):1068-1082. PubMed ID: 31625560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TALE never ends: A comprehensive overview of the role of PBX1, a TALE transcription factor, in human developmental defects.
    Mary L; Leclerc D; Gilot D; Belaud-Rotureau MA; Jaillard S
    Hum Mutat; 2022 Sep; 43(9):1125-1148. PubMed ID: 35451537
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Le Tanno P; Breton J; Bidart M; Satre V; Harbuz R; Ray PF; Bosson C; Dieterich K; Jaillard S; Odent S; Poke G; Beddow R; Digilio MC; Novelli A; Bernardini L; Pisanti MA; Mackenroth L; Hackmann K; Vogel I; Christensen R; Fokstuen S; Béna F; Amblard F; Devillard F; Vieville G; Apostolou A; Jouk PS; Guebre-Egziabher F; Sartelet H; Coutton C
    J Med Genet; 2017 Jul; 54(7):502-510. PubMed ID: 28270404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An example of parenchymal renal sparing in the context of complex malformations due to a novel mutation in the PBX1 gene.
    Ruscitti F; Cerminara M; Iascone M; Pezzoli L; Rosti G; Romano F; Ronchetto P; Martucciello G; Buratti S; Buffelli F; Bocciardi R; Puliti A; Divizia MT
    Birth Defects Res; 2022 Jul; 114(12):674-681. PubMed ID: 35751431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying Signalling Pathways Regulated by GPRC5B in β-Cells by CRISPR-Cas9-Mediated Genome Editing.
    Atanes P; Ruz-Maldonado I; Hawkes R; Liu B; Persaud SJ; Amisten S
    Cell Physiol Biochem; 2018; 45(2):656-666. PubMed ID: 29408822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Silencing PBX1 expression induces apoptosis and ROS production of lung cancer cells].
    Yao XP; Peng HX; Wu JR
    Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):843-848. PubMed ID: 33113625
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chromosomal large fragment deletion induced by CRISPR/Cas9 gene editing system].
    Cheng LH; Liu Y; Niu T
    Zhonghua Xue Ye Xue Za Zhi; 2017 May; 38(5):427-431. PubMed ID: 28565744
    [No Abstract]   [Full Text] [Related]  

  • 10. Cas9-nickase-mediated genome editing corrects hereditary tyrosinemia in rats.
    Shao Y; Wang L; Guo N; Wang S; Yang L; Li Y; Wang M; Yin S; Han H; Zeng L; Zhang L; Hui L; Ding Q; Zhang J; Geng H; Liu M; Li D
    J Biol Chem; 2018 May; 293(18):6883-6892. PubMed ID: 29507093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo, deleterious sequence variants that alter the transcriptional activity of the homeoprotein PBX1 are associated with intellectual disability and pleiotropic developmental defects.
    Slavotinek A; Risolino M; Losa M; Cho MT; Monaghan KG; Schneidman-Duhovny D; Parisotto S; Herkert JC; Stegmann APA; Miller K; Shur N; Chui J; Muller E; DeBrosse S; Szot JO; Chapman G; Pachter NS; Winlaw DS; Mendelsohn BA; Dalton J; Sarafoglou K; Karachunski PI; Lewis JM; Pedro H; Dunwoodie SL; Selleri L; Shieh J
    Hum Mol Genet; 2017 Dec; 26(24):4849-4860. PubMed ID: 29036646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NANOG Attenuates Hair Follicle-Derived Mesenchymal Stem Cell Senescence by Upregulating PBX1 and Activating AKT Signaling.
    Liu F; Shi J; Zhang Y; Lian A; Han X; Zuo K; Liu M; Zheng T; Zou F; Liu X; Jin M; Mu Y; Li G; Su G; Liu J
    Oxid Med Cell Longev; 2019; 2019():4286213. PubMed ID: 31885790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of the TALE-code reveals aberrantly activated homeobox gene PBX1 in Hodgkin lymphoma.
    Nagel S; Pommerenke C; Meyer C; MacLeod RAF; Drexler HG
    PLoS One; 2021; 16(2):e0246603. PubMed ID: 33539429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paternal mosaicism for a novel PBX1 mutation associated with recurrent perinatal death: Phenotypic expansion of the PBX1-related syndrome.
    Arts P; Garland J; Byrne AB; Hardy TSE; Babic M; Feng J; Wang P; Ha T; King-Smith SL; Schreiber AW; Crawford A; Manton N; Moore L; Barnett CP; Scott HS
    Am J Med Genet A; 2020 May; 182(5):1273-1277. PubMed ID: 32141698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA-uc.40 silence promotes P19 embryonic cells differentiation to cardiomyocyte via the PBX1 gene.
    Wu R; Xue P; Wan Y; Wang S; Gu M
    In Vitro Cell Dev Biol Anim; 2018 Sep; 54(8):600-609. PubMed ID: 30112697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical Control of a CRISPR/Cas9 System for Gene Editing by Using Photolabile crRNA.
    Zhang Y; Ling X; Su X; Zhang S; Wang J; Zhang P; Feng W; Zhu YY; Liu T; Tang X
    Angew Chem Int Ed Engl; 2020 Nov; 59(47):20895-20899. PubMed ID: 33448579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CRISPR AcrIIA5 Potently Inhibits All Cas9 Homologs Used for Genome Editing.
    Garcia B; Lee J; Edraki A; Hidalgo-Reyes Y; Erwood S; Mir A; Trost CN; Seroussi U; Stanley SY; Cohn RD; Claycomb JM; Sontheimer EJ; Maxwell KL; Davidson AR
    Cell Rep; 2019 Nov; 29(7):1739-1746.e5. PubMed ID: 31722192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A piggyBac-based toolkit for inducible genome editing in mammalian cells.
    Schertzer MD; Thulson E; Braceros KCA; Lee DM; Hinkle ER; Murphy RM; Kim SO; Vitucci ECM; Calabrese JM
    RNA; 2019 Aug; 25(8):1047-1058. PubMed ID: 31101683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency.
    Jensen KT; Fløe L; Petersen TS; Huang J; Xu F; Bolund L; Luo Y; Lin L
    FEBS Lett; 2017 Jul; 591(13):1892-1901. PubMed ID: 28580607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Construction of Nalm6-Cas9 Cell Line for Genome-Wide Translocation Sequencing].
    Li QC; Huang JB; Xue HM; Yang M; Zhu CM; Li CK; Dong JC; Chen C
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1384-1390. PubMed ID: 36208239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.